<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[breast cancer Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/breast+cancer.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to breast cancer]]></description>
	<s:counts start="0" returned="20" found="301" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Merck KGaA on Cancer Vaccines: We're Not Crazy, Just Convinced]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003090/merck-kgaa-on-cancer-vaccines-were-not-crazy-just-convinced/]]></link>
		<description><![CDATA[Merck KGaA claims they arenÃ¢â‚¬â„¢t crazy for initiating a Phase III breast cancer trial with the therapeutic cancer vaccine Stimuvax -- theyÃ¢â‚¬â„¢re just completely convinced the darn thing is going to work. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 13 Jul 2009 22:24:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[Breast Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Is Merck KGaA Crazy? Or Just Crazy About Cancer Vaccines?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002833/is-merck-kgaa-crazy-or-just-crazy-about-cancer-vaccines/]]></link>
		<description><![CDATA[Merck KGaAÃ¢â‚¬â„¢s decision to start a Phase III trial in breast cancer with the therapeutic cancer vaccine Stimuvax -- which failed a Phase II lung cancer trial and is untested in breast cancer -- begs the question: Has the German big pharma gone nuts? by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 23 Jun 2009 21:44:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[Breast Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+kgaa.html"><![CDATA[Merck KGaA]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[ARIAD Pharmaceuticals Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-268231.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Jim Birchenough from Barclays Capital. Please proceed sir.  Ryan Martins - Barclays Capital Hi, actually this is Ryan Martins in for Jim Birchenough, thanks for taking my call. I was wondering if you guys could give...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 12 Feb 2009 07:53:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[Breast Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/barclays+plc..html"><![CDATA[Barclays Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/prostate.html"><![CDATA[Prostate]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/ariad+pharmaceuticals+inc..html"><![CDATA[ARIAD Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer+trial.html"><![CDATA[Breast Cancer Trial]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARIA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
		<category domain="tickers">ARIA,BCS</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Roche's DTC Regrets, Novartis and Mylan, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000452/pharma-roundup-roches-dtc-regrets-novartis-and-mylan-and-more/]]></link>
		<description><![CDATA[Roche CEO: DTC ads industry's "worst decision." Novartis and Mylan reach patent deal. Trouble in Biotech-land. AmerisourceBergen and its thrifty CEO. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 02 Dec 2008 17:44:51 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[Breast Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[China Med Wins Approval for Breast Cancer Probe]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F105740-china-med-wins-approval-for-breast-cancer-probe%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:   China Medical Technologies CMED received SFDA approval for its Breast Cancer HER2 FISH probe. Breast cancer patients are routinely tested for overexpression of HER2 protein because overexpression is associated with a higher incidence of recurrence and also predicts a better response to Genentech&#8217;s DNA breast...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 12 Nov 2008 11:13:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[Breast Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/probe.html"><![CDATA[Probe]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/china+medical+technologies.html"><![CDATA[China Medical Technologies]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer+patient.html"><![CDATA[Breast Cancer Patient]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
	</item>
	<item>
		<title><![CDATA[Affymetrix Technology Powers First Genomic Tumor Grading Test for Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_30/ai_n25469000]]></link>
		<description><![CDATA[Ipsogen's MapQuant Dx[TM] Genomic Grade is designed to improve treatment decisions through a more precise molecular test]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 30 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_27/ai_n25454835]]></link>
		<description><![CDATA[Results from Studies of Other Investigational Merck Cancer Medicines, Including the IGF-1R inhibitor (MK-0646), also Presented at ASCO]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[women]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Mayo Clinic Researchers Discover Novel Approach to Estimate Risk of Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_1/ai_n25376271]]></link>
		<description><![CDATA[ROCHESTER, Minn. -- In a paper published today, a team of medical researchers from the Mayo Clinic in collaboration with academic colleagues from Myriad Genetics Laboratories, the University of Utah, France, and Australia report on the outcome of a study that analyzes the risk for breast cancer imparted by inherited...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Aetna Teams Up with American Cancer Society to Help Improve the Odds in the Fight Against Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_29/ai_n25361744]]></link>
		<description><![CDATA[New Video and Outreach Program Emphasizes Importance of Annual Mammograms, Addresses Barriers to Screening]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aetna+inc..html"><![CDATA[Aetna Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/american+cancer+society.html"><![CDATA[American Cancer Society]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/team.html"><![CDATA[team]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AET</category>
		<category domain="tickers">AET</category>
	</item>
	<item>
		<title><![CDATA[BT Test for Breast Cancer Now Covered by Insurance]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_29/ai_n25361883]]></link>
		<description><![CDATA[Women pay no out-of-pocket cost for Provista Life Sciences' groundbreaking early breast cancer detection test]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/british+telecommunications.html"><![CDATA[British Telecommunications]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[insurance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BTY</category>
		<category domain="tickers">BTY</category>
	</item>
	<item>
		<title><![CDATA[RiverStone Journals Launches Organizer for Women with Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_28/ai_n25359643]]></link>
		<description><![CDATA[A Survivor's Guide for the Breast Cancer Journey]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/riverstone.html"><![CDATA[Riverstone]]></category>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[women]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_22/ai_n25339939]]></link>
		<description><![CDATA[NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that it has reached agreement with the U.S. Food and Drug Administration FDA under a Special Protocol Assessment SPA for its planned Phase III clinical trial...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 22 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Provista Life Sciences & Sonora Quest Laboratories Team Up on the BT Test&#153;, A New Blood Test for Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_3/ai_n24359359]]></link>
		<description><![CDATA[Sonora Quest Laboratories to Provide Phlebotomy Services]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Mar 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/british+telecommunications.html"><![CDATA[British Telecommunications]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BTY</category>
		<category domain="tickers">BTY</category>
	</item>
	<item>
		<title><![CDATA[Abviva Announces Patent Issuance for Core Technology Used in Mammastatin Serum Assay Diagnostic Test for Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_21/ai_n24320056]]></link>
		<description><![CDATA[LOS ANGELES -- Abviva, Inc. Abviva (OTCBB:AVVA), a biomedical company engaged in the innovation, development and commercialization of breast cancer diagnostic and therapeutic applications of Mammastatin, announced today that the United States Patent and Trademark Office issued a pivotal patent on the core technology used in the Company's breast cancer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 21 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+michigan.html"><![CDATA[University of Michigan]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Calibrant Announces Ovarian and Breast Cancer Drug Discovery Partnership with Yale University]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_7/ai_n24251920]]></link>
		<description><![CDATA[GAITHERSBURG, Md. -- Calibrant Biosystems today announced a research collaboration with the Yale University School of Medicine to identify novel ovarian and breast cancer drug targets from clinical tissue specimens using Calibrant's Gemini proteomics platform. Calibrant will identify proteins and protein networks involved in ovarian and breast cancer, as well...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/yale+university.html"><![CDATA[Yale University]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Safeway Donates Over $1.3 Million for Critical Breast Cancer Research and Prevention Programs in Western Washington]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_19/ai_n27479758]]></link>
		<description><![CDATA[BELLEVUE, Wash. -- Safeway Inc. (NYSE: SWY) today announced it donated $1,365,185.13 for critical breast cancer research and prevention programs in Western Washington. The announcement follows a month-long breast cancer fundraising and public service campaign in all of Safeway's stores where customers, employees and suppliers joined together in making donations...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/safeway+plc..html"><![CDATA[Safeway Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_15/ai_n21157269]]></link>
		<description><![CDATA[A Study Evaluating Twice Yearly Dosing with Denosumab Met All Primary and Secondary Endpoints]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 15 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/pivotal+corp..html"><![CDATA[Pivotal Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Roche to Announce New Breast Cancer Data Pointing to Better Survival Chances and Potential for Cure.(Clinical report)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200712/ai_n23673750]]></link>
		<description><![CDATA[BASEL, Switzerland, December 10 /PRNewswire/ --    BASEL, Switzerland, December 10 /PRNewswire/ --  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Amgen Announces Interim Results of Aranesp® "PREPARE" Study in Breast Cancer Patients]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_30/ai_n21131269]]></link>
		<description><![CDATA[THOUSAND OAKS, Calif. -- Amgen, Inc. (NASDAQ: AMGN) today announced that it had received interim results from the independent investigator-sponsored "PREPARE" study, an open-label, randomized, multicenter Phase 3 study of Aranesp([R]) darbepoetin alfa in 733 neoadjuvant breast cancer patients receiving dose-dense, dose-intense preoperative chemotherapy compared to a standard preoperative chemotherapy...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 30 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/aranesp.html"><![CDATA[Aranesp]]></category>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[BBN Technologies' Stereoscopic Digital Mammography Technology Shows Major Advance In Breast Cancer Screening Through More Accurate Detection of Breast Lesions]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_28/ai_n27457629]]></link>
		<description><![CDATA[False-Positive Reports of Breast Lesions Reduced by 49 percent in Clinical Trial]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 28 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/breast+cancer.html"><![CDATA[breast cancer]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
